Protective V127 prion variant prevents prion disease by interrupting the formation of dimer and fibril from molecular

Shuangyan Zhou1,2, Danfeng Shi2, Xuewei Liu2

  • 1School of Pharmacy, Lanzhou University, Lanzhou 730000, China.

Scientific Reports
|February 25, 2016
PubMed

Insights

The V127 prion protein variant resists prion conversion by disrupting dimer and fibril formation. This molecular insight explains its protective effect against prion diseases.

Area of Science:

  • Molecular Biology
  • Biophysics
  • Neuroscience

Background:

  • Prion diseases are linked to misfolded prion proteins.
  • A protective V127 variant of prion protein (PrP) shows resistance to conversion.
  • The structural basis for V127's protective effect remains unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms behind the protective V127 variant.
  • To explore how the G127V mutation influences prion propagation processes.
  • To understand the structural basis of V127's resistance to prion conversion.

Main Methods:

  • Molecular dynamics simulations were employed.
  • Simulations focused on prion dimerization and fibril formation.
  • Analysis of hydrogen bond interactions and binding energies was performed.

Main Results:

  • The V127 variant destabilizes prion dimer formation by reducing H-bonds.
  • V127 incorporation leads to unstable and disordered prion fibrils.
  • Weaker inter-layer interactions and fewer H-bonds indicate reduced fibril stability.

Conclusions:

  • The V127 variant is unfavorable for both dimer and stable fibril formation.
  • This study elucidates the molecular mechanism of V127's protective role.
  • Findings may guide the development of therapeutics for prion diseases.